Amrize Ltd.: Wells Fargo cuts target price to $40 from $44
AMRZ•Wells Fargo cut its target price for Amrize to $40 from $44.
Related News
Maravai Lifesciences Holdings initiates coverage with buy rating; target price $9
MRVI•
C.H. Robinson to buy RXO for $5.8 billion
CHRW•
ECARX completes acquisition of Flyme software business for RMB 1.8 billion
ECX•
Herbalife finance chief Schaefer to hold one-on-one meetings at Maxim Growth Summit
HLF•
BMO cuts Westlake Corp target price to $81 from $82
WLK•